Scott Johnson
Urology · Milwaukee, WINPI 1912223553
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (30.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Urogen Pharma, Inc. at 36.5% of the total.
Across 15 payments — averaging $385.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogen Pharma, Inc.$2K
- Sanofi$2K
- Intuitive Surgical$2K
- Johnson & Johnson$220
- Novo Nordisk$124
Across 2 payments — averaging $17,078 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$34K
What the payments were for
- Consulting fees$1,78831%
- Speaking & faculty fees$1,50026%
- Travel & lodging$1,54127%
- Food & beverage$94616%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogen Pharma, Inc. | 7 | $2,111 |
| Sanofi | 1 | $1,788 |
| Intuitive Surgical | 4 | $1,541 |
| Johnson & Johnson | 2 | $220 |
| Novo Nordisk | 1 | $124 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,783 in reported general payments places this provider in the 85th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 102 | $1,349 |
| Solifenacin Succinate | 19 | $657 |
| Finasteride | 36 | $530 |
Paid to pharmacies, not to this prescriber.
Other urology in Milwaukee
- Amy GuiseMilwaukee$106K
- Mark WaplesMilwaukee$15K
- Robert OconnorMilwaukee$12K
- Matthew JohnsonMilwaukee$10K
- Peter LeonoviczMilwaukee$9K
- Arjun SivaramanMilwaukee$8K
- Graham MachenMilwaukee$7K
- Luriel Smith-HarrisonMilwaukee$5K
- Charles KiddMilwaukee$5K
- Pedro BandaMilwaukee$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.